Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :


By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :


Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

T2 Biosystems Inc. TTOO

"T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. Its core technology is the T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease."

View modes: 

RE:it was a buy this morning for me

Just saying One time "Hi" here. Rating: SELL. Come back: MAY later.  rate and reply

it's a sell today for me

the technical chart showed a failure to support the $3 per share mark from yesterday,so got out this morning at $2.93 per share,made a profit of over $1 per share for a couple of days work,glta.  rate and reply

C.BOSS Appoints Head of Sales w/ Expertise in Edible Mushroom Wellness Products

The global edible mushrooms market is expected to grow at a CAGR of 7.95% to grow to US$62 billion by 2023, increasing from US$42 billion in 2018, according to a report by Research and Markets. Grand View Research reports that the global healthy snacks market size is expected to reach US$32 billion by 2025. more

still holding this stock and

watching it go up steadily,it might be a double for me this week,but it was only purchased yesterday,so glta and please DYODD.  rate and reply

it was a buy this morning for me

it cost me $1.85 per share,it was on my watch list and it looks like it will do well,but DYODD.  rate and reply


Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.